Exploring the Validity of Valproic Acid Animal Model of Autism

被引：177
|
作者：
Mabunga, Darine Froy N. [1 ,2 ,3 ]
Gonzales, Edson Luck T. [1 ,2 ,3 ]
Kim, Ji-woon [1 ,2 ,3 ]
Kim, Ki Chan [1 ,2 ,3 ]
Shin, Chan Young [1 ,2 ,3 ,4 ]
机构：
[1] Konkuk Univ, Dept Neurosci, Sch Med, Seoul 05029, South Korea
[2] Konkuk Univ, Neurosci Res Ctr, SMART IABS, Seoul 05029, South Korea
[3] Konkuk Univ, KU Open Innovat Ctr, Seoul 05029, South Korea
[4] Konkuk Univ, Sch Med, Dept Pharmacol, Seoul 05029, South Korea
来源：
EXPERIMENTAL NEUROBIOLOGY | 2015年 / 24卷 / 04期
基金：
新加坡国家研究基金会;
关键词：
autism spectrum disorder; construct validity; face validity; predictive validity; animal model; social communication deficit; INCREASED OXIDATIVE STRESS; NEURAL-TUBE DEFECTS; SPECTRUM DISORDERS; PRENATAL EXPOSURE; ENVIRONMENTAL ENRICHMENT; REPETITIVE BEHAVIOR; SOCIAL-INTERACTION; THERAPEUTIC APPROACH; ADDITIONAL EVIDENCE; MENTAL-RETARDATION;
D O I：
10.5607/en.2015.24.4.285
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The valproic acid (VPA) animal model of autism spectrum disorder (ASD) is one of the most widely used animal model in the field. Like any other disease models, it can't model the totality of the features seen in autism. Then, is it valid to model autism? This model demonstrates many of the structural and behavioral features that can be observed in individuals with autism. These similarities enable the model to define relevant pathways of developmental dysregulation resulting from environmental manipulation. The uncovering of these complex pathways resulted to the growing pool of potential therapeutic candidates addressing the core symptoms of ASD. Here, we summarize the validity points of VPA that may or may not qualify it as a valid animal model of ASD.
引用
收藏
页码：285 / 300
页数：16
相关论文
共 50 条
  • [21] Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism
    Hirsch, Mauro Mozael
    Deckmann, Iohanna
    Santos-Terra, Julio
    Staevie, Gabriela Zanotto
    Fontes-Dutra, Mellanie
    Carello-Collar, Giovanna
    Korbes-Rockenbach, Marilia
    Schwingel, Gustavo Brum
    Bauer-Negrini, Guilherme
    Rabelo, Bruna
    Bittencourt Goncalves, Maria Carolina
    Correa-Velloso, Juliana
    Naaldijk, Yahaira
    Geciauskas Castillo, Ana Regina
    Schneider, Tomasz
    Bambini-Junior, Victorio
    Ulrich, Henning
    Gottfried, Carmem
    NEUROPHARMACOLOGY, 2020, 167
  • [22] Transcriptional and splicing dysregulation in the prefrontal cortex in valproic acid rat model of autism
    Zhang, Ruoxin
    Zhou, Jinlong
    Ren, Junrong
    Sun, Siqi
    Di, Yuanyuan
    Wang, Hanyu
    An, Xiaoqin
    Zhang, Kexin
    Zhang, Junfeng
    Qian, Zhaoqiang
    Shi, Meimei
    Qiao, Yanning
    Ren, Wei
    Tian, Yingfang
    REPRODUCTIVE TOXICOLOGY, 2018, 77 : 53 - 61
  • [23] Early Behavioral Abnormalities and Perinatal Alterations of PTEN/AKT Pathway in Valproic Acid Autism Model Mice
    Yang, Eun-Jeong
    Ahn, Sangzin
    Lee, Kihwan
    Mahmood, Usman
    Kim, Hye-Sun
    PLOS ONE, 2016, 11 (04):
  • [24] Elevated microRNA-181c and microRNA-30d levels in the enlarged amygdala of the valproic acid rat model of autism
    Loohuis, N. F. M. Olde
    Kole, K.
    Glennon, J. C.
    Karel, P.
    Van der Borg, G.
    Van Gemert, Y.
    Van den Bosch, D.
    Meinhardt, J.
    Kos, A.
    Shahabipour, F.
    Tiesinga, P.
    van Bokhoven, H.
    Martens, G. J. M.
    Kaplan, B. B.
    Homberg, J. R.
    Aschrafi, A.
    NEUROBIOLOGY OF DISEASE, 2015, 80 : 42 - 53
  • [25] Neonatal Oxytocin Treatment Ameliorates Autistic-Like Behaviors and Oxytocin Deficiency in Valproic Acid-Induced Rat Model of Autism
    Dai, Yu-Chuan
    Zhang, Hong-Feng
    Schon, Michael
    Boeckers, Tobias M.
    Han, Song-Ping
    Han, Ji-Sheng
    Zhang, Rong
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 12
  • [26] Amelioration of cognition impairments in the valproic acid-induced animal model of autism by ciproxifan, a histamine H3-receptor antagonist
    Taheri, Farahnaz
    Esmaeilpour, Khadijeh
    Sepehri, Gholamreza
    Sheibani, Vahid
    Shekari, Majid Asadi
    BEHAVIOURAL PHARMACOLOGY, 2023, 34 (04): : 179 - 196
  • [27] Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid
    Schneider, Tomasz
    Roman, Adam
    Basta-Kaim, Agnieszka
    Kubera, Marta
    Budziszewska, Bogustawa
    Schneider, Karolina
    Przewtocki, Ryszard
    PSYCHONEUROENDOCRINOLOGY, 2008, 33 (06) : 728 - 740
  • [28] The protective effect of prenatally administered vitamin E on behavioral alterations in an animal model of autism induced by valproic acid
    Langari, Ahmad Alinaghi
    Nejadi, Akram
    Kameshki, Halimeh
    Jorjafki, Sobhan Mohammadi
    Mirhosseini, Yasamin
    Khaksari, Mohammad
    Meymandi, Manzumeh Shamsi
    Nozari, Masoumeh
    TOXIN REVIEWS, 2021, 40 (04) : 676 - 680
  • [29] Alterations of neocortical development and maturation in autism: Insight from valproic acid exposure and animal models of autism
    Chomiak, Taylor
    Hu, Bin
    NEUROTOXICOLOGY AND TERATOLOGY, 2013, 36 : 57 - 66
  • [30] The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism
    Naghdi, Mohammad Reza
    Ahadi, Reza
    Nezhad, Ali Motamed
    Tabatabaei, Faeze Sadat Ahmadi
    Soleimani, Mansoureh
    Hajisoltani, Razieh
    BRAIN RESEARCH, 2024, 1838
12345